SurgePays Files New $100M Shelf as Going-Concern Doubts Persist
SURG sits 34% above its 52-week low of $0.114.
Summary
SurgePays filed a new $100 million shelf registration, mostly carried-over unsold capacity, giving it the ability to sell stock and other securities over time while it works through going-concern and Nasdaq listing issues.
Key Events · Financing and Capital Events · SURG
-
New $100M Universal Shelf Filed
Registration covers up to $100,000,000 of common stock, preferred stock, debt securities, warrants, rights and units, sellable from time to time after effectiveness. No securities have been sold under it.
-
Mostly Carried-Over Capacity
Only $11,531,927.56 is newly registered (a $1,003.28 filing fee); $88,468,072.44 of unsold securities and $9,749.18 of prepaid fees carry forward from the prior S-3 (File No. 333-273110) under Rule 415(a)(6).
-
Float Cap Limits Near-Term Sales
Public float is $9,270,401 (62,062,796 shares outstanding, 8,507,619 affiliate-held, at $0.1731 on September 11, 2026), so I.B.6 caps primary sales at one-third of float per 12 months while float stays under $75 million.
-
Heavy Prior-Year Share Sales
The company has already sold 26,226,877 shares for $10,374,900 gross under I.B.6 in the trailing 12 months, showing the shelf is an active funding channel, not a dormant one.
Analysis · SURG · Technology
SurgePays has registered up to $100 million of stock, preferred, debt, warrants, rights and units for sale 'from time to time' — permission to raise capital, not a sale. Only $11.5 million of that is newly registered; the other $88.5 million is unsold capacity carried over from the prior shelf. The real weight is context: this company's last 10-Q carried going-concern doubt and Nasdaq delisting risk, and it has already sold 26.2 million shares for $10.4 million in the past year. A fresh shelf on top of that means more equity issuance is the likely path to funding, and the I.B.6 one-third-of-float cap limits how much can be sold in any 12 months while the float stays under $75 million. Watch for 424B supplements — those are the actual dilution events.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2240 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SURG was trading at $0.15 on NASDAQ in the Technology sector, with a market capitalization of approximately $8.1M. The 52-week trading range was $0.11 to $2.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.